Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Nucl Med Biol. 2009 Aug;36(6):651–658. doi: 10.1016/j.nucmedbio.2009.03.008

Table 3.

Biodistribution data with [11C]WC-98

Organ Group % ID/g tissue (mean ± SD)
5 min* 30 min**
Blood Treated 2.328 0.205 ± 0.048
Control 1.797 ± 0.040 0.148 ± 0.022
Liver Treated 2.885 1.170 ± 0.085†
Control 2.533 ± 0.417 0.621 ± 0.041
Spleen Treated 1.413 0.323 ± 0.091
Control 0.982 ± 0.088 0.201 ± 0.035
Muscle Treated 0.088 0.103 ± 0.012
Control 0.117 ± 0.010 0.108 ± 0.007
Fat Treated 0.070 0.074 ± 0.020‡
Control 0.099 ± 0.021 0.130 ± 0.010
Heart Treated 1.154 0.242 ± 0.048
Control 0.950 ± 0.020 0.193 ± 0.021
Lung Treated 1.534 0.294 ± 0.089
Control 1.181 ± 0.104 0.239 ± 0.026
Thymus Treated 0.288 0.159 ± 0.022
Control 0.227 ± 0.061 0.120 ± 0.009
*

N=2 for the treated group and N=3 for the control group. Therefore, statistical analysis was not performed. Only the mean is reported for the treated group.

**

N=4 in both treated and control groups at 30 min.

†

p < 0.05 when comparing treated to control. Statistical analysis was applied only to the 30 minute data as the number of animals in each group at 5 minutes, after elimination of animals with bad injections, was too small.

‡

p < 0.05. Note that the level of tracer uptake is higher in the control rather than in the treated group.

%ID/g = % injected dose per gram; SD = standard deviation